NCT05895032 Trial of an Exercise Intervention for Children With Haemophilia
| NCT ID | NCT05895032 |
| Status | Recruiting |
| Phase | — |
| Sponsor | East Kent Hospitals University NHS Foundation Trust |
| Condition | Hemophilia |
| Study Type | INTERVENTIONAL |
| Enrollment | 132 participants |
| Start Date | 2021-05-06 |
| Primary Completion | 2025-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 132 participants in total. It began in 2021-05-06 with a primary completion date of 2025-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
"Being able to participate in games and activities with their friends" is one of the things that matters most to boys with haemophilia. At present, there is a lack of robust evidence to determine whether muscle strengthening exercise can improve or negatively affect outcomes for young children with haemophilia. With the help of boys with haemophilia, their parents and physiotherapists the investigators have developed an exercise programme designed to increase muscle strength. Using this intervention the investigators will undertake a single-blinded, two-arm pragmatic randomised controlled trial (RCT) of a 12-week intervention verses usual care of boys with haemophilia aged 6-12 years of age.
Eligibility Criteria
Inclusion Criteria: • Children aged 6-12 years, with severe or moderate haemophilia A or B Exclusion Criteria: * von Willebrand disease * past history of fracture or trauma to the lower limb * orthopaedic surgery * acquired brain injury or any other disturbance of the central nervous system; joint or muscle bleed in the lower limb in the past 6 weeks * presence of lower limb pain or unable to fully comply with verbal instructions.
Contact & Investigator
David Stephensen, PhD
STUDY CHAIR
East Kent Hospitals University NHS Foundation Trust
Frequently Asked Questions
Who can join the NCT05895032 clinical trial?
This trial is open to male participants only, aged 6 Years or older, up to 12 Years, studying Hemophilia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05895032 currently recruiting?
Yes, NCT05895032 is actively recruiting participants. Contact the research team at david.stephensen@nhs.net for enrollment information.
Where is the NCT05895032 trial being conducted?
This trial is being conducted at Canterbury, United Kingdom.
Who is sponsoring the NCT05895032 clinical trial?
NCT05895032 is sponsored by East Kent Hospitals University NHS Foundation Trust. The principal investigator is David Stephensen, PhD at East Kent Hospitals University NHS Foundation Trust. The trial plans to enroll 132 participants.